Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety

Ferdinando Riccardi, Michele Orditura, Anna Diana et al.|Molecular and Clinical Oncology|2018

Cited by 14